Akouos Shares 2011-2026 | AKUS

Annual Shares Akouos

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
34.4 M	17.6 M	606 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
34.4 M	606 K	17.5 M

Quarterly Shares Akouos

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	36.9 M	35.8 M	34.5 M	34.5 M	34.5 M	34.4 M	34.3 M	34.4 M	15.3 M	1.12 M	708 K	997 K	622 K	587 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.9 M	587 K	21.3 M

Shares of other stocks in the Biotechnology industry

Issuer	Shares	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	38.7 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	4.73 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	85.1 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	543 M	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	50 M	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	192 M	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	1.55 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	224 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	4.28 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	9.34 B	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	229 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	98.5 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	54.9 B	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	120 M	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	89.9 M	$ 50.55	2.25 %	$ 4.55 B	Schweiz
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	22.6 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	68.9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	66.4 M	$ 29.94	1.99 %	$ 1.99 B	USA
Generation Bio Co. GBIO	66.6 M	-	-	$ 344 M	USA
IMV IMV	8.34 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	2.19 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	59.3 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	338 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	14.3 M	$ 14.78	-1.1 %	$ 212 M	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	3.17 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 2.86	-1.38 %	$ 4.71 M	Israel
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Enlivex Therapeutics Ltd. ENLV	45.7 M	$ 0.69	2.29 %	$ 31.5 M	Israel
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	19.2 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	88.8 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	127 M	$ 24.97	7.49 %	$ 3.18 B	USA
Allena Pharmaceuticals ALNA	68 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA